Some firms target T cell jabs in fight against Covid variants

It found that the antibody response of current vaccines could fail against variants. However, a second immune response in the form of killer T cells -- which attack already infected cells and not the virus itself -- remained largely intact.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3uHK34w
via IFTTT